Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 1
1993 3
1994 3
1997 2
1998 3
1999 4
2000 3
2001 2
2003 2
2004 3
2006 1
2007 6
2008 5
2010 1
2011 2
2014 3
2015 3
2016 4
2017 1
2018 1
2019 1
2020 3
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Calabrese JR, Durgam S, Satlin A, Vanover KE, Davis RE, Chen R, Kozauer SG, Mates S, Sachs GS. Calabrese JR, et al. Among authors: vanover ke. Am J Psychiatry. 2021 Dec;178(12):1098-1106. doi: 10.1176/appi.ajp.2021.20091339. Epub 2021 Sep 23. Am J Psychiatry. 2021. PMID: 34551584 Clinical Trial.
Pharmacology of N-desmethylclozapine.
Lameh J, Burstein ES, Taylor E, Weiner DM, Vanover KE, Bonhaus DW. Lameh J, et al. Among authors: vanover ke. Pharmacol Ther. 2007 Aug;115(2):223-31. doi: 10.1016/j.pharmthera.2007.05.004. Epub 2007 May 21. Pharmacol Ther. 2007. PMID: 17583355 Review.
PDE Inhibitors for the Treatment of Schizophrenia.
Snyder GL, Vanover KE. Snyder GL, et al. Among authors: vanover ke. Adv Neurobiol. 2017;17:385-409. doi: 10.1007/978-3-319-58811-7_14. Adv Neurobiol. 2017. PMID: 28956340 Review.
Effect Size and Blinding in Lumateperone Trial-Reply.
Correll CU, Lakkis HD, Vanover KE. Correll CU, et al. Among authors: vanover ke. JAMA Psychiatry. 2020 Jun 1;77(6):651-652. doi: 10.1001/jamapsychiatry.2020.0613. JAMA Psychiatry. 2020. PMID: 32320025 No abstract available.
58 results